We market well.
Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.
Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.
Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.
(Reuters) - U.S. health insurers will send out about $330 million in rebates to employers and individuals this summer under President Barack Obama's healthcare law, the U.S. Department of Health and Human Services said on Thursday.... WASHINGTON (Reuters) - An estimated 10.3 million American adults have gained health coverage since Obamacare enrollment began last October, with the biggest gains among young adults and Hispanics, according to a study published on Wednesday.... WASHINGTON (Reuters) - The director of a U.S. government bioterror lab that potentially exposed scores of workers to live anthrax last month has resigned, the U.S. Centers for Disease Control and Prevention said on Wednesday.... SHANGHAI (Reuters) - China's food regulator has visited close to 600 restaurants, businesses and food distributors as it investigates a fast-spreading food safety scare that has dragged in a number of global brands and hit food outlets as far away as Japan.... SAN FRANCISCO (Reuters) - San Francisco city leaders have approved a measure for the November ballot that would place a two-cents-per-ounce municipal tax on sodas and other sugary beverages, hoping to become the first major city to successfully impose such a levy.... SAN FRANCISCO (Reuters) - Federal Trade Commissioner Julie Brill, speaking in Washington on Wednesday, expressed concern about the way apps on smartphones and mobile devices are siphoning sensitive health data, and how some of that information may then be shared with third parties.... (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer.... LONDON (Reuters) - Paracetamol, a painkiller universally recommended to treat people with acute low back pain, does not speed recovery or reduce pain from the condition, according to the results of a large trial published on Thursday.... WASHINGTON (Reuters) - U.S. rules that ensure prescription medicines are not misused have been manipulated by brand-name drug companies to fight off generic competitors, costing consumers billions of dollars, according to a report released on Wednesday.... SEOUL (Reuters) - South Korea has confirmed a case of foot-and-mouth disease at a hog farm, the country's first outbreak in more than three years, the agriculture ministry said in a statement on Thursday....